1. Lipocalin 2 in the pathogenesis of fatty liver disease and nonalcoholic steatohepatitis
   Anastasia Asimakopoulou et al, 2015, Clinical Lipidology CrossRef
2. Lipocalin 2—A bone‐derived anorexigenic and β‐cell promoting signal: From mice to humans
   Yuying Yang et al, 2024, Journal of Diabetes CrossRef
3. Biological Functions and Therapeutic Potential of Lipocalin 2 in Cancer
   Ginette S. Santiago-Sánchez et al, 2020, International Journal of Molecular Sciences CrossRef
4. Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology
   Rikki A. M. Brown et al, 2020, Frontiers in Oncology CrossRef
5. Iron Dysregulation in Human Cancer: Altered Metabolism, Biomarkers for Diagnosis, Prognosis, Monitoring and Rationale for Therapy
   Pierre Lelièvre et al, 2020, Cancers CrossRef
6. A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
   Marinela Krizanac et al, 2021, International Journal of Molecular Sciences CrossRef
7. Chronic Carbon Tetrachloride Applications Induced Hepatocyte Apoptosis in Lipocalin 2 Null Mice through Endoplasmic Reticulum Stress and Unfolded Protein Response
   Erawan Borkham-Kamphorst et al, 2020, International Journal of Molecular Sciences CrossRef
8. Lipocalin-2 inhibits pancreatic cancer stemness via the AKT/c-Jun pathway
   Peipei Hao et al, 2022, Human Cell CrossRef
9. Osteoblast‐derived extracellular vesicles exert osteoblastic and tumor‐suppressive functions via SERPINA3 and LCN2 in prostate cancer
   Kagenori Ito et al, 2023, Molecular Oncology CrossRef